| Literature DB >> 26490384 |
Jeffrey M Peters1, Frank J Gonzalez2, Rolf Müller3.
Abstract
The role of the nuclear hormone receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in carcinogenesis is controversial because conflicting studies indicate that it both inhibits and promotes tumorigenesis. In this review, we focus on recent studies on PPARβ/δ including the significance of increased or decreased PPARβ/δ expression in cancers; a range of opposing mechanisms describing how PPARβ/δ agonists, antagonists, and inverse agonists regulate tumorigenesis and/or whether there may be cell context-specific mechanisms; and whether activating or inhibiting PPARβ/δ is feasible for cancer chemoprevention and/or therapy. Research questions that need to be addressed are highlighted to establish whether PPARβ/δ can be effectively targeted for cancer chemoprevention.Entities:
Keywords: cancer; chemoprevention; mechanisms; peroxisome proliferator-activated receptor-β/δ; transcription factor
Mesh:
Substances:
Year: 2015 PMID: 26490384 PMCID: PMC4631629 DOI: 10.1016/j.tem.2015.09.004
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015